Fundación de Investigación

San Juan 909

0 studies enrolling now · 2 studies all time

What they study most

Diabetic Kidney Disease (DKD), Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Studies at this site

• Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early